|DVT Awareness | Join Our Email List | Sunday, April 23, 2017|
Find Information on a:
View all Postings for:
Prasugrel (New Antiplatelet Agent) Approved in Europe
Marie B. Walker
While controversy has surrounded the FDA Panel's review of Prasugrel in the US, the drug has been approved by the European Commission. Prasugrel will be marketed as Efient in Europe.
Copyright 2000-2012 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to firstname.lastname@example.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.